Clinical Trial: Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Atopic Dermatitis
Study Type: INTERVENTIONAL
Official Title: A Phase 2a Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of ATI-2138 Administered Over 12 Weeks in Participants With Moderate to Severe Ato
Brief Summary:
This is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.
Read more